![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-218x150.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
No needles, no nasal administration – only a easy oral vaccine to guard in opposition to many frequent viruses, from the flu to Covid.
ALLENTOWN, PENNSYLVANIA, UNITED STATES, October 31, 2022/EINPresswire.com/ — Finding essentially the most comfy, handy vaccine to guard in opposition to chilly and flu season is usually a feat with a restricted pool of choices. But there’s a kinder vaccine in improvement at US Specialty Formulations (USSF): QYNDR. The cutting-edge oral vaccine was created in response to the U.S. authorities’s name for extra COVID-19 vaccines and is being clinically examined and could also be a profitable but versatile possibility in opposition to many viruses and sicknesses, from frequent colds, flus and Covid to West Nile, MERS, Ebola and Nipah.
“QYNDR is a vaccine that we developed out of urgency but that has, as a result of extensive clinical trials, become a feasible solution to better protection against not only SARS-CoV-2 but a range of viruses. In early 2020, our bio-tech firm was approaching the clinical trial stage of an oral DTaP vaccine and was able to pivot the development to create QYNDR. Through induction of mucosal IgA and serum IgG, this vaccine will make administration, adherence, and protection better and more accessible for all,” stated USSF Co-Founder and CEO Dr. Kyle Flanigan, PhD.
The protein-based oral vaccine (also referred to as a mucosal vaccine) was formulated by Dr. Flanigan, USSF Co-Founder and COO Dr. Garry Morefield, PhD, and their achieved staff of scientists. With many years of expertise within the a number of levels of pharmaceutical improvement and medical efficiency supplies, Dr. Flanigan and Dr. Morefield established a posh resolution for a simple-to-take vaccine supported by intensive analysis that oral vaccines boast quite a few benefits over injectables. Here is the precise USSF Clinical trials entry: https://clinicaltrials.gov/ct2/show/NCT04893512
These benefits embrace:
• Fewer unwanted side effects and longer-lasting safety: After taking QYNDR, acceptable ranges of antibodies persist for a big period of time with none noticed unfavorable unwanted side effects. By including a mucosal oral vaccine to enrich the world’s vaccine mRNA arsenal, populations may be protected in opposition to viruses longer as a result of its ease of use.
• Adaptable: Oral vaccines have proven cross-strain protecting functionality and thus are uniquely positioned to be up to date as viruses mutate.
• Convenient: QYNDR line of vaccines don’t require medical administration earlier than it may be administered – all one should do is open the bottle and drink.
• Reduced danger of transmission (shedding): Recent information exhibits that even immunized individuals proceed to ‘shed’ reside viruses of their surroundings after publicity. This mucosal-type vaccine notably reduces the quantity of virus within the mucosa, thus decreasing the danger of virus shedding and stopping the unfold.
• Supplying the demand: QYNDR will help meet the underserved demand for international vaccines, which is increased than what 1 or 2 massive suppliers within the U.S. can present. It doesn’t require a chilly chain (refrigeration) to move, distribute or retailer, thus making it extra accessible.
With funding for added testing, QYNDR has the potential to change into an over-the-counter vaccine. USSF has already accomplished the primary stage of medical trials for the oral-dosage vaccine and has proceeded into the second and third levels. USSF will proceed to endure closing levels medical trials and funding initiatives earlier than saying QYNDR’s official launch date.
About USSF
USSF is a minority-controlled business that may be a licensed Current Good Manufacturing Practice (cGMP) producer of sterile injectable, topical and specialty prescribed drugs. It manufactures its personal branded prescription merchandise, along with offering medical supplies for investigational new drug functions, specialty formulations, adjuvants and fermentation and purification companies requested by quite a lot of biotech corporations.
To hold updated on the most recent concerning the QYNDR vaccine, please go to USSF on-line.
###
EDITOR’S NOTE: For extra details about USSF and to rearrange to talk with an organization spokesperson, please contact Nancy Trent or Pamela Wadler at 212-966-0024 or [email protected].
Pamela Wadler
Trent & Company
e mail us right here
![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-100x70.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
